Who
Paul Hideo Opgenorth
Vice President, Development
Company insider
Files Form 4 as: Vice President, Development, eXoZymes.
In numbers
- Trades disclosed
- 4
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 8 Nov 2024
- Last trade
- 1 Apr 2026
- Last filed
- 8 Apr 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 1 Apr 2026filed 8 Apr 2026 | EXOZ eXoZymesBiotechnology | SEC FORM 4 Code A | $34K3,999 at $8.44 | filing |
| 1 Apr 2026filed 8 Apr 2026 | EXOZ eXoZymesBiotechnology | SEC FORM 4 Code A | $34K3,999 at $8.44 | filing |
| 13 Jun 2025filed 17 Jun 2025 | EXOZ eXoZymesBiotechnology | SEC FORM 4 Code A | $37K2,990 at $12.54 | filing |
| 8 Nov 2024filed 18 Nov 2024 | EXOZ eXoZymesBiotechnology | SEC FORM 4 Code C | $15K2,344 at $6.40 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.